Concord Biotech IPO GMP : The information provide in this article covers a range of details regarding the Concord Biotech IPO, including today’s GMP (Grey Market Premium), the price of shares, the current subscription status, the lot size, and important dates. Are you keeping an eye on the stock market? If so, you may have heard about the Concord Biotech IPO. Initial Public Offerings (IPOs) can be an exciting time for investors, as they offer the opportunity to get in on the ground floor of a promising company. But what exactly is the Concord Biotech IPO GMP? In this blog post, we’ll break down what GMP means in relation to IPOs, and why it’s important to pay attention to this metric when considering investing in a company. So if you’re curious about the Concord Biotech IPO and want to learn more about its GMP, keep reading!
If you’re an investor looking for the next big opportunity, youmay have heard about the Concord Biotech IPO. But what exactly is the GMP? In this blog post, we’ll break down what GMP means in the context of an IPO and why it’s important to consider when evaluating an investment. We’ll also discuss the potential benefits and risks associate with investing in Concord Biotech. So if you’re curious about the GMP and want to learn more about this exciting IPO, keep reading!
Concord Biotech IPO GMP
Concord Biotech, a research and development focused biopharmaceutical company, is set to go public and list on the stock market. The Initial Public Offering (IPO) of this company will be available for purchase from August 4th, 2023 to August 8th, 2023. Each share of this company has a face value of Rs 1. Keep an eye out for Concord Biotech as it becomes list on the stock market.
The current Gross Market Premium (GMP) for the Concord Biotech Initial Public Offering (IPO) stands at Rs 260 per share. Potential buyers should be aware that the price range for these shares is set between Rs 705 and Rs 741. Establish in 2000, this company has gain international recognition for its products, which are available in approximately 70 countries. In addition to its presence in India, Concord Biotech has establish markets in various regions including the USA, Europe, Japan, and Africa.
Concord Biotech IPO GMP Details
| Opening Date of Concord Biotech IPO | 4th August 2023 |
| Closing Date | 8th August 2023 |
| Basis of Allotment | 11th August 2023 |
| Refunds Initiated on | 14th August 2023 |
| Shares Credited on | 17th August 2023 |
| Listing of IPO | 18th August 2023 |
| Expiry Date of UPI Mandatory | 8th August 2023 |
| Category | News |
 |
|
 |
|
| Telegram |  |
| Official Website | www.concordbiotech.com |
Also Check: Rajasthan New Districts Name List 2023
Concord Biotech IPO Share Price
The IPO of Concord Biotech Limit will commence on August 4, 2023, with the company offering a total of 20,925,652 shares at a price range of Rs 705 to Rs 741 per share. Interest buyers are advise to place their bids promptly. The listing of this company’s shares on the BSE and NSE is schedule for August 18, 2023.
Prior to making any investment in this particular company, it is important that you familiarize yourself with its historical performance and financial gains. Additionally, it is worth noting that there are several other competing companies list in the stock market, such as Divi’s Laboratories, Suven Pharmaceuticals, Laurus Labs, and Shilpa Medicare.
Check Here: School Assembly News Headlines Today 2023
Concord Biotech IPO Subscription Status
The start date for the Concord Biotech IPO subscription will be on August 4, 2023. To take part in this initial public offering, individuals are require to log into their broker’s application or website and locate the IPO section. Within the IPO section, a variety of currently accessible IPOs can be discover.
To begin, choose Concord Biotech from the menu and click on the “Invest in IPO” choice. Before you continue, please ensure that you log in using your login details, which consist of your name, mobile number, or unique ID along with your password. After successfully logging in, you will be require to make a payment in order to finalize the subscription. It is important to note that the funds will be temporarily held and not transfer to any other account.
Look Here: Raksha Bandhan 2023
Concord Biotech IPO Lot Size
The price per share of Concord Biotech is expect to range from Rs 705 to Rs 741. Additionally, it is important to note that the minimum investment for any IPO is approximately Rs 15000. Therefore, the lot size for the Concord Biotech IPO is set at 20 shares, requiring a minimum investment of Rs 14820. Investors have the option to purchase a maximum of 260 shares, which is equivalent to 13 lots.
Therefore, an individual who has only one broker can allocate a maximum amount of Rs 192,660 at a share price of Rs 741. If you intend to participate in the bidding process for this initial public offering (IPO), it is important to note that the deadline for submission is the 8th of August, 2023. In order to obtain comprehensive information about this IPO, you will need to contact your broker and request all relevant details.
Read More: Andhra Pradesh New Capital 2023
Concord Biotech IPO Date
The date for the Concord Biotech IPO has already been announce, and you can find out more by reading this article. The registration process for the Concord Biotech IPO will commence on August 4th, 2023. Those interest in purchasing shares of this company can do so by accessing their broker’s app or website, or by directly contacting their broker.
Please take note that the deadline for subscribing to the Concord Biotech IPO is August 8, 2023. We highly recommend purchasing the IPO as soon as possible via the broker’s website or application. Information regarding the subscription status will be made available during the third week of August 2023.
In order to obtain comprehensive information regarding the Concord Biotech IPO, it is necessary to access the application or website of the broker you are communicating with. Additionally, our website offers a wealth of details that can be found in our articles.
Concord Biotech IPO GMP FAQ’S
What is the GMP of Concord Biotech?
The current grey market premium (GMP) for the Concord Biotech IPO is ₹126. The grey market anticipates that the listing price for the IPO will be approximately ₹867 (₹741 + ₹126), which is about 17 percent higher than the price band of ₹705 to ₹741 per equity share for the Concord Biotech IPO.
What is the premium price of Concord Biotech IPO?
Concord Biotech IPO Listing: Concord Biotech made a stellar debut on the stock exchanges Friday. The shares of Concord Biotech were listed with a premium of 21.46% at ₹900.05 apiece on the BSE, as compared to the issue price of Rs 741 per share.
What is the GMP of Windlas biotech?
Windlas Biotech IPO GMP is ₹85 as on today.
Is Concord Biotech a good IPO?
The brokerage has expressed the view that the IPO is appropriately priced and has suggested subscribing to it for the long term. Concord's revenue has shown a compound annual growth rate (CAGR) of 18% from FY21 to FY23, with an EBITDA margin of 40%. The company's return ratios are robust, with a return on equity (RoE) and return on capital employed (RoCE) of 20% and 19%, respectively. Additionally, Concord has generated free cash flow over the past two years, with a free cash flow to EBITDA ratio of 29%.
Related Post:
Netweb Technologies India Limited 2023
